Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies… Grant US-9737617-B2 United States of America 22 Aug 2017
Combination therapy with anti-CD74 and anti-CD20 antibodies provides enhanced toxicity to… Grant US-9359443-B2 United States of America 07 Jun 2016
Antibody IgG1 with a modified heavy chain constant region Application EP-2966085-A1 European Patent Office 13 Jan 2016
Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies… Grant US-8906378-B2 United States of America 09 Dec 2014
Multiple signaling pathways induced by hexvalent, monospecific and bispecific antibodies… Grant US-8871216-B2 United States of America 28 Oct 2014
Combination therapy with anti-CD74 antibodies provides enhanced toxicity to malignancies… Grant US-8475794-B2 United States of America 02 Jul 2013
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies… Grant US-8349332-B2 United States of America 08 Jan 2013
Structural variants of antibodies for improved therapeutic characteristics Grant US-8287864-B2 United States of America 16 Oct 2012
Therapeutical use of antibody inducing the production of cytokines Application EP-2092939-A3 European Patent Office 21 Dec 2011
Anti-CD20 antibodies and fusion proteins thereof and methods of use Grant US-8057793-B2 United States of America 15 Nov 2011
Structural variants of antibodies for improved therapeutic characteristics Grant US-7919273-B2 United States of America 05 Apr 2011
Anti-CD20 antibodies and fusion proteins thereof and methods of use Grant US-7435803-B2 United States of America 14 Oct 2008
Anti-CD20 antibodies and fusion proteins thereof and methods of use Grant US-7151164-B2 United States of America 19 Dec 2006